Zyversa Therapeutics Inc
(ZVSA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2017 | |
| Operating Expenses | 9,137 | 107,754 | 13,833 | 7,704 | 0 |
| Operating Income | -9,137 | -107,754 | -13,833 | -7,704 | N/A |
| Interest Expense | 270 | -1 | 428 | 821 | 0 |
| Other Income | 0 | 0 | -607 | 442 | 0 |
| Pre-tax Income | -9,407 | -107,754 | -14,868 | -8,084 | 0 |
| Income Tax | 7 | -9,456 | -745 | N/A | N/A |
| Net Income Continuous | -9,413 | -98,298 | -14,123 | -8,084 | N/A |
| Net Income | $-9,413 | $-98,298 | $-14,123 | $-8,084 | $N/A |
| EPS Basic Total Ops | -8.48 | -1,089.70 | -935.60 | -115.38 | N/A |
| EPS Basic Continuous Ops | -8.48 | -1,008.18 | -547.39 | -116.96 | N/A |
| EPS Diluted Total Ops | -8.48 | -1,089.70 | -935.60 | -115.38 | N/A |
| EPS Diluted Continuous Ops | -8.48 | -1,008.18 | -547.39 | -116.96 | N/A |
| EPS Diluted Before Non-Recurring Items | -8.48 | -967.70 | N/A | N/A | N/A |
| EBITDA(a) | $-9,130 | $-95,849 | $-13,783 | $-7,376 | $N/A |